BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 32269318)

  • 21. High CFTR expression in Philadelphia chromosome-positive acute leukemia protects and maintains continuous activation of BCR-ABL and related signaling pathways in combination with PP2A.
    Yang X; Yan T; Gong Y; Liu X; Sun H; Xu W; Wang C; Naren D; Zheng Y
    Oncotarget; 2017 Apr; 8(15):24437-24448. PubMed ID: 28445932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PP2A impaired activity is a common event in acute myeloid leukemia and its activation by forskolin has a potent anti-leukemic effect.
    Cristóbal I; Garcia-Orti L; Cirauqui C; Alonso MM; Calasanz MJ; Odero MD
    Leukemia; 2011 Apr; 25(4):606-14. PubMed ID: 21233840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hematologically important mutations: Shwachman-Diamond syndrome.
    Costa E; Santos R
    Blood Cells Mol Dis; 2008; 40(2):183-4. PubMed ID: 17916435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mitotic spindle destabilization and genomic instability in Shwachman-Diamond syndrome.
    Austin KM; Gupta ML; Coats SA; Tulpule A; Mostoslavsky G; Balazs AB; Mulligan RC; Daley G; Pellman D; Shimamura A
    J Clin Invest; 2008 Apr; 118(4):1511-8. PubMed ID: 18324336
    [TBL] [Abstract][Full Text] [Related]  

  • 25. TGFβ signaling underlies hematopoietic dysfunction and bone marrow failure in Shwachman-Diamond Syndrome.
    Joyce CE; Saadatpour A; Ruiz-Gutierrez M; Bolukbasi OV; Jiang L; Thomas DD; Young S; Hofmann I; Sieff CA; Myers KC; Whangbo J; Libermann TA; Nusbaum C; Yuan GC; Shimamura A; Novina CD
    J Clin Invest; 2019 Jun; 129(9):3821-3826. PubMed ID: 31211692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of novel PP2A activators for use in the treatment of acute myeloid leukaemia.
    Toop HD; Dun MD; Ross BK; Flanagan HM; Verrills NM; Morris JC
    Org Biomol Chem; 2016 May; 14(20):4605-16. PubMed ID: 27102578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. EFL1 mutations impair eIF6 release to cause Shwachman-Diamond syndrome.
    Tan S; Kermasson L; Hoslin A; Jaako P; Faille A; Acevedo-Arozena A; Lengline E; Ranta D; Poirée M; Fenneteau O; Ducou le Pointe H; Fumagalli S; Beaupain B; Nitschké P; Bôle-Feysot C; de Villartay JP; Bellanné-Chantelot C; Donadieu J; Kannengiesser C; Warren AJ; Revy P
    Blood; 2019 Jul; 134(3):277-290. PubMed ID: 31151987
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cucurbitacin B induces inhibitory effects via the CIP2A/PP2A/C-KIT signaling axis in t(8;21) acute myeloid leukemia.
    Ma W; Xiang Y; Yang R; Zhang T; Xu J; Wu Y; Liu X; Xiang K; Zhao H; Liu Y; Si Y
    J Pharmacol Sci; 2019 Apr; 139(4):304-310. PubMed ID: 30852180
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Shwachman-Bodian-Diamond syndrome gene encodes an RNA-binding protein that localizes to the pseudopod of Dictyostelium amoebae during chemotaxis.
    Wessels D; Srikantha T; Yi S; Kuhl S; Aravind L; Soll DR
    J Cell Sci; 2006 Jan; 119(Pt 2):370-9. PubMed ID: 16410554
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic analysis of Shwachman-Diamond syndrome: phenotypic heterogeneity in patients carrying identical SBDS mutations.
    Kawakami T; Mitsui T; Kanai M; Shirahata E; Sendo D; Kanno M; Noro M; Endoh M; Hama A; Tono C; Ito E; Tsuchiya S; Igarashi Y; Abukawa D; Hayasaka K
    Tohoku J Exp Med; 2005 Jul; 206(3):253-9. PubMed ID: 15942154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Shwachman-Diamond SBDS protein localizes to the nucleolus.
    Austin KM; Leary RJ; Shimamura A
    Blood; 2005 Aug; 106(4):1253-8. PubMed ID: 15860664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features and gene mutations of children with Shwachman-Diamond syndrome and malignant myeloid transformation].
    An WB; Liu C; Wan Y; Chang LX; Chen XY; Zhu XF
    Zhongguo Dang Dai Er Ke Za Zhi; 2020 May; 22(5):460-465. PubMed ID: 32434641
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Shwachman-Diamond syndrome and solid tumors: Three new patients from the French Registry for Severe Chronic Neutropenia and literature review.
    Bou Mitri F; Beaupain B; Flejou JF; Patient M; Okhremchuck I; Blaise D; Izadifar-Legrand F; Martignoles JA; Delhommeau F; Bellanne-Chantelot C; Emile JF; Donadieu J
    Pediatr Blood Cancer; 2021 Jul; 68(7):e29071. PubMed ID: 33871916
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure, dynamics, and RNA interaction analysis of the human SBDS protein.
    de Oliveira JF; Sforça ML; Blumenschein TM; Goldfeder MB; Guimarães BG; Oliveira CC; Zanchin NI; Zeri AC
    J Mol Biol; 2010 Mar; 396(4):1053-69. PubMed ID: 20053358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Influence of PP2A activator on proliferation of HL-60 cells and analysis of PP2A activity changes in patients with acute myeloid leukemia].
    Yang Y; Li XQ; Huang Q; Huang SA
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Jun; 19(3):594-7. PubMed ID: 21729530
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Shwachman-Bodian-Diamond syndrome associated protein interacts with HsNip7 and its down-regulation affects gene expression at the transcriptional and translational levels.
    Hesling C; Oliveira CC; Castilho BA; Zanchin NI
    Exp Cell Res; 2007 Dec; 313(20):4180-95. PubMed ID: 17643419
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel Drosophila model for neurodevelopmental disorders associated with Shwachman-Diamond syndrome.
    Takai A; Chiyonobu T; Ueoka I; Tanaka R; Tozawa T; Yoshida H; Morimoto M; Hosoi H; Yamaguchi M
    Neurosci Lett; 2020 Nov; 739():135449. PubMed ID: 33115644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of Shwachman-Bodian-Diamond syndrome protein in translation machinery and cell chemotaxis: a comparative genomics approach.
    Vasieva O
    Adv Appl Bioinform Chem; 2011; 4():43-50. PubMed ID: 22046100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of PPP2R5E is a common event in acute myeloid leukemia that affects the oncogenic potential of leukemic cells.
    Cristóbal I; Cirauqui C; Castello-Cros R; Garcia-Orti L; Calasanz MJ; Odero MD
    Haematologica; 2013 Sep; 98(9):e103-4. PubMed ID: 23812941
    [No Abstract]   [Full Text] [Related]  

  • 40. Penfluridol triggers cytoprotective autophagy and cellular apoptosis through ROS induction and activation of the PP2A-modulated MAPK pathway in acute myeloid leukemia with different FLT3 statuses.
    Wu SY; Wen YC; Ku CC; Yang YC; Chow JM; Yang SF; Lee WJ; Chien MH
    J Biomed Sci; 2019 Aug; 26(1):63. PubMed ID: 31470848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.